Get started Log in

GNFT — Genfit SA Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Market Cap
€445.36m
Enterprise Value
€510.81m
Revenue
€65.43m

Genfit: Drops on workforce reduction, bigger loss
01/10/2020 15:42
Brief: Genfit To Reduce Cash Burn By More Than 50% By 2022, With 40% Workforce Reduction
01/10/2020 07:48
Genfit: Tops SBF after commercial agreement with Labcorp for NASH test
28/09/2020 08:54
Brief: Genfit And Labcorp Sign Exclusive Agreement To Commercialize A Novel Diagnostic Test For Liver Disease
28/09/2020 07:10
Genfit SA: Rises on announcing Phase 3 study to evaluate liver disease drug
25/09/2020 14:19
Brief: Genfit Announces First Patient First Visit For Elative Phase 3 Study Evaluating Elafibranor In PBC
24/09/2020 21:43
Brief: Genfit Announces Pivotal Publication Of NIS4 Technology
05/08/2020 07:38
Brief: Genfit Provides Initial Update on Corporate Strategy
23/07/2020 07:31
Brief: Genfit Q1 Revenues Up At 102,000 Euros
19/05/2020 06:58
Intercept Pharma: Citi downgrades, sees lower likelihood of liver drug's success
12/05/2020 13:50
Brief: GENFIT Announces Trial of Elafibranor Did Not Show Significant Effect On NASH Patients
12/05/2020 10:39
Genfit: Sinks after disappointing elafibranor phase 3 results
12/05/2020 10:13
NASDAQ RESUMED AT 03:35 PM
11/05/2020 21:35
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:13 PM
11/05/2020 21:13
Advisory: Alert on Genfit withdrawn
16/04/2020 07:48
Brief: Genfit Says All Other Clinical Trials Have Been Paused Or Postponed Due To Pandemic
08/04/2020 22:06
Factbox: Coronavirus hits drugmakers as clinical trials delayed
03/04/2020 19:45
Brief: Genfit Puts On Hold All Its Phase 1 Trials Due To COVID-19 Pandemic
31/03/2020 08:15
NASDAQ RESUMED AT 02:43 PM
17/03/2020 19:43
NASDAQ RESUMED AT 02:38 PM
17/03/2020 19:38